CFGS
RDY icon

Concourse Financial Group Securities’s Dr. Reddy's Laboratories RDY Stock Holding History

Concourse Financial Group Securities’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-35
Closed -$276 – 2122
2019
Q3 		$0 Buy
+35
New +$260 ﹤0.01% 2072

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Concourse Financial Group Securities's RDY Position: Q4 2019 in Review

Concourse Financial Group Securities sold out of Dr. Reddy's Laboratories (RDY) in Q4 2019, closing a stake of 35 shares — an estimated $276 sold.

Concourse Financial Group Securities first reported a position in RDY in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 148 funds tracked by Wall St. Rank hold RDY as of Q4 2019.

  • Concourse Financial Group Securities reported no remaining Dr. Reddy's Laboratories position as of Q4 2019 after selling out during the quarter.
  • Concourse Financial Group Securities sold 35 Dr. Reddy's Laboratories shares in Q4 2019, an estimated $276.
  • Concourse Financial Group Securities first reported a position in Dr. Reddy's Laboratories in Q3 2019 and held it in 1 quarter.
  • Concourse Financial Group Securities's Dr. Reddy's Laboratories position peaked at $0 in Q3 2019.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2019.

Based on Concourse Financial Group Securities's 13F filing for Q4 2019, filed 14 Feb 2020.